The management of combined coronary artery disease and peripheral vascular disease
Coronary artery disease (CAD) and peripheral vascular disease (PVD) remain highly prevalent in the population due to population ageing, smoking, diabetes, unhealthy lifestyles, and the epidemic of obesity, and frequently coexist. The management of combined CAD and PVD is a common challenge and brings with it numerous clinical dilemmas. The goal of this article is to review the prevalence of PVD and its major impact upon prognosis in patients with known CAD and in turn to review the impact of CAD upon the prognosis of patients with PVD. This review will also highlight issues related to the peri-operative evaluation and management of patients going to vascular surgery, including medical optimization as well as the performance and timing of coronary revascularization. Published on behalf of the European Society of Cardiology. All rights reserved.
|Keywords||Coronary artery disease, Kaplan Meier method, Non-cardiac vascular surgery, Peri-operative management, Peripheral vascular disease, acetylsalicylic acid, algorithm, angiotensin receptor antagonist, bleeding, carotid artery obstruction, carotid endarterectomy, case management, clopidogrel, comorbidity, coronary artery disease, coronary risk, coronary stent, diet restriction, dipeptidyl carboxypeptidase inhibitor, drug eluting stent, fibrinogen receptor antagonist, heart infarction, heart muscle revascularization, human, mortality, percutaneous coronary intervention, peripheral vascular disease, postoperative complication, preoperative care, priority journal, prognosis, review, treatment planning, vascular surgery|
|Persistent URL||dx.doi.org/10.1093/eurheartj/ehq186, hdl.handle.net/1765/20688|
|Journal||European Heart Journal|
|Note||Free full text at PubMed|
Cassar, A, Poldermans, D, Rihal, C.S, & Gersh, B.J. (2010). The management of combined coronary artery disease and peripheral vascular disease. European Heart Journal, 31(13), 1565–1572. doi:10.1093/eurheartj/ehq186